Dr Mara Zeissig
Group Head, T Cell Immunotherapy Laboratory
South Australian Immunogenomics Cancer Institute
Faculty of Health and Medical Sciences
Eligible to supervise Masters and PhD - email supervisor to discuss availability.
Dr Zeissig completed her PhD at the South Australian Health and Medical Research Institute (SAHMRI) in 2020 with Prof Andrew Zannettino, followed by a postdoc at Monash University (2020-2022) with Prof Tony Tiganis in Melbourne. She then commenced a postdoc at WEHI in Melbourne with Prof Kate Sutherland in 2022. Her work was focused on modulating the tumour microenvironment to enhance anti-tumour immunity and improve response to immunotherapy. In 2025 Dr Mara Zeissig relocated to Adelaide to set up the T cell Immunotherapy Lab. Summer scholarship, Honours, Masters and PhD projects are available: https://www.adelaide.edu.au/saigenci/ua/media/719/saigenci-student-research-opportunities.pdf
Mara Zeissig's research lab is focused on improving response to T-cell based immunotherapies in solid cancers, with a focus on lung and pancreatic cancers. We use a range of approaches, including genetically engineered mouse models and sophisticated CRISPR-Cas9 genetic screening techniques to understand how tumours evade the immune system and identify immune modulators to increase the efficacy of immunotherapy in solid tumours.
-
Appointments
Date Position Institution name 2024 - ongoing Group Head University of Adelaide 2022 - ongoing Senior Research Officer Walter and Eliza Hall Institute of Medical Research 2020 - 2022 Research Officer Monash University -
Language Competencies
Language Competency German Can read, speak and understand spoken Spanish - Latin American Can read, write, speak and understand spoken -
Education
Date Institution name Country Title 2013 - 2015 University of Adelaide Australia Bachelor of Science (Advanced) University of Adelaide Australia PhD (Medicine) -
Research Interests
-
Journals
-
Conference Papers
Year Citation 2017 Zeissig, M. N., Hewett, D. R., Martin, S., Mrozik, K. M., Cheong, C. M., Diamond, P., . . . Zannettino, A. C. W. (2017). HIF-2α Upregulates CCR1 to Promote Dissemination of Plasma Cells in Multiple Myeloma. In BLOOD Vol. 130 (pp. 2 pages). Atlanta, GA: AMER SOC HEMATOLOGY. -
Conference Items
Year Citation 2019 Zeissig, M. N., Hewett, D. R., Mrozik, K. M., Panagopoulos, V., Engelhardt, M., To, L. B., . . . Vandyke, K. (2019). Therapeutic Targeting of CCR1 to Prevent Dissemination of Multiple Myeloma Plasma Cells. Poster session presented at the meeting of BLOOD. FL, Orlando: ELSEVIER.
DOI
2025 - 2026 Tour De Cure Early Career Research Grant
2023 - 2024 Cure Cancer Australia Foundation Early Career Researcher Grant
2023 - 2026 Victorian Cancer Agency Early Career Fellowship
-
Current Higher Degree by Research Supervision (University of Adelaide)
Date Role Research Topic Program Degree Type Student Load Student Name 2025 Principal Supervisor Enhancing T cell anti-tumour activity Doctor of Philosophy Doctorate Full Time Mr Wuyu Lin
Connect With Me
External Profiles
